BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 62515)

  • 21. Three novel mouse monoclonal antibodies, OM-A, OM-B, and OM-C, reactive with mucinous type ovarian tumors.
    Sakakibara K; Ueda R; Ohta M; Nakashima N; Tomoda Y; Takahashi T
    Cancer Res; 1988 Aug; 48(16):4639-45. PubMed ID: 2456145
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of a tumor antigen TA-4 of squamous cell carcinoma in relation to its appearance in the circulation.
    Kato H; Nagaya T; Torigoe T
    Gan; 1984 May; 75(5):433-5. PubMed ID: 6745563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunodiagnosis of ovarian cancer].
    Zhang J; Cao Z; Sun Z; Sun Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):325-8. PubMed ID: 1748422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Initial immunochemical characterization of MX35 ovarian cancer antigen.
    Welshinger M; Yin BW; Lloyd KO
    Gynecol Oncol; 1997 Nov; 67(2):188-92. PubMed ID: 9367706
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further characterization of CSAp, an antigen associated with gastrointestinal and ovarian tumors.
    Pant KD; Dahlman HL; Goldenberg DM
    Cancer; 1978 Sep; 42(3 Suppl):1626-34. PubMed ID: 81713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein.
    Garin-Chesa P; Campbell I; Saigo PE; Lewis JL; Old LJ; Rettig WJ
    Am J Pathol; 1993 Feb; 142(2):557-67. PubMed ID: 8434649
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of two different surface epitopes of human ovarian epithelial carcinomas by monoclonal antibodies.
    Tsuji Y; Suzuki T; Nishiura H; Takemura T; Isojima S
    Cancer Res; 1985 May; 45(5):2358-62. PubMed ID: 2580620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification of human ovarian tumor-associated antigen and demonstration of circulating tumor antigen in patients with advanced ovarian malignancy.
    Knauf S; Urbach GI
    Am J Obstet Gynecol; 1977 Apr; 127(7):705-10. PubMed ID: 66873
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
    Tosner J; Fixa B
    Clin Exp Immunol; 1979 Nov; 38(2):356-60. PubMed ID: 527267
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New antigens induced by herpes simplex virus in human tumors].
    Posevaia TA; Grigor'ev VV; Kosiakova NP; Barinskiĭ IF
    Vopr Virusol; 1981; (2):193-5. PubMed ID: 6267821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunochemical identification of beta2-globulin in metastases of ovarian tumors].
    Prokopenko PG; Borisenko SA; Tatarinov IuS
    Biull Eksp Biol Med; 1988 Jul; 106(7):81-3. PubMed ID: 3042035
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mouse monoclonal antibodies to human epithelial differentiation antigens expressed on the surface of ovarian carcinoma ascites cells.
    Mattes MJ; Look K; Furukawa K; Pierce VK; Old LJ; Lewis JL; Lloyd KO
    Cancer Res; 1987 Dec; 47(24 Pt 1):6741-50. PubMed ID: 3677104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Sharing antigenic determinant of colon carcinoma between serous and mucinous tumors of the ovary].
    Liu MP; Lu ZT; Chen W
    Zhonghua Fu Chan Ke Za Zhi; 1994 Jul; 29(7):398-400, 444. PubMed ID: 7528120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Generation of monoclonal antibodies reacting with human epithelial ovarian cancer.
    Tagliabue E; Mènard S; Della Torre G; Barbanti P; Mariani-Costantini R; Porro G; Colnaghi MI
    Cancer Res; 1985 Jan; 45(1):379-85. PubMed ID: 3965146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Characterization of two antigens OC41 D and OC41 E associated with ovarian carcinoma].
    Cui H
    Zhonghua Fu Chan Ke Za Zhi; 1993 May; 28(5):284-6, 314-5. PubMed ID: 8243148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Organ-specific human prostate beta-globulin during tumor growth].
    Nikolaev AA; Afanas'eva AV; Khaĭrullin IuKh
    Biull Eksp Biol Med; 1980 Nov; 90(11):583-6. PubMed ID: 6160885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunochemical study of antigens in the ascitic fluid of patients with ovarian cancer].
    Sergeeva NS; Vasil'ev MIu; Avdeev GI
    Eksp Onkol; 1986; 8(4):37-40. PubMed ID: 3757883
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoperoxidase localization of a high-molecular-weight mucin recognized by monoclonal antibody 1D3.
    Gangopadhyay A; Bhattacharya M; Chatterjee SK; Barlow JJ; Tsukada Y
    Cancer Res; 1985 Apr; 45(4):1744-52. PubMed ID: 3884144
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor associated antigen in ovarian carcinoma.
    Negishi Y; Mutai Y; Akiya K; Fujiwara Y; Singh G
    Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):126-32. PubMed ID: 6199439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
    Nakamura S
    Acta Obstet Gynaecol Jpn; 1981 Jul; 33(7):1015-24. PubMed ID: 6171133
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.